These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34897375)

  • 1. The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.
    Morel T; Cano S; Bartlett SJ; Gordon C; Haier B; Regnault A; Schneider M; Stach C; Cleanthous S
    Rheumatology (Oxford); 2022 Aug; 61(8):3329-3340. PubMed ID: 34897375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Uncertainty Questionnaire-Rheumatology (PUQ-R): development and validation of a new patient-reported outcome instrument for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a mixed methods study.
    Cleanthous S; Isenberg DA; Newman SP; Cano SJ
    Health Qual Life Outcomes; 2016 Mar; 14():33. PubMed ID: 26927364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
    Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
    Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN).
    Williams-Hall R; Berry P; Williamson N; Barclay M; Roberts A; Gater A; Tolley C; Bradley H; Ward A; Hsia E; Zuraw Q; DeLong P; Touma Z; Strand V
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review.
    Strand V; Simon LS; Meara AS; Touma Z
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32591423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
    Cleanthous S; Mork AC; Regnault A; Cano S; Kaminski HJ; Morel T
    Orphanet J Rare Dis; 2021 Oct; 16(1):457. PubMed ID: 34717694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.
    Askanase AD; Daly RP; Okado M; Neville K; Pong A; Hanrahan LM; Merrill JT
    Health Qual Life Outcomes; 2019 Jun; 17(1):99. PubMed ID: 31174541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.
    Mathias SD; Berry P; De Vries J; Askanase A; Pascoe K; Colwell HH; Chang DJ
    Health Qual Life Outcomes; 2017 Feb; 15(1):43. PubMed ID: 28245854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies.
    Cleanthous S; Bongardt S; Marquis P; Stach C; Cano S; Morel T
    Rheumatol Ther; 2021 Sep; 8(3):1287-1301. PubMed ID: 34244970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma.
    Barrett L; Elliott E; Voorhaar M; Ingelgård A; Griebsch I; Wong B; Mills J; Heinrich P; Cano S
    Oncol Ther; 2023 Mar; 11(1):129-143. PubMed ID: 36633810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.
    Vaccarino AL; Kalali AH; Blier P; Gilbert Evans S; Engelhardt N; Foster JA; Frey BN; Greist JH; Kobak KA; Lam RW; MacQueen G; Milev R; Müller DJ; Parikh SV; Placenza FM; Rizvi SJ; Rotzinger S; Sheehan DV; Sills T; Soares CN; Turecki G; Uher R; Williams JBW; Kennedy SH; Evans KR
    Innov Clin Neurosci; 2020 Jul; 17(7-9):30-40. PubMed ID: 33520402
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis.
    López-Pina JA; Meseguer-Henarejos AB; Gascón-Cánovas JJ; Navarro-Villalba DJ; Sinclair VG; Wallston KA
    Health Qual Life Outcomes; 2016 Sep; 14(1):128. PubMed ID: 27619635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples.
    Petrillo J; Cano SJ; McLeod LD; Coon CD
    Value Health; 2015 Jan; 18(1):25-34. PubMed ID: 25595231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the patient-reported outcome for older people living with HIV/AIDS in China (PROHIV-OLD).
    Zhou R; Zheng YJ; Wang BJ; Patrick DL; Edwards TC; Yun JY; Zhou J; Gu RJ; Miao BH; Wang HM
    Health Qual Life Outcomes; 2024 Apr; 22(1):30. PubMed ID: 38561752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.
    Zigler CK; Ardalan K; Lane S; Schollaert KL; Torok KS
    Br J Dermatol; 2020 Mar; 182(3):625-635. PubMed ID: 31498874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PU-PROM: A patient-reported outcome measure for peptic ulcer disease.
    Liu N; Lv J; Liu J; Zhang Y
    Health Expect; 2017 Dec; 20(6):1350-1366. PubMed ID: 28636163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.